Interchange Capital Partners
RXRX icon

Interchange Capital Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Interchange Capital Partners’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$52.6K Sell
12,724
-715
-5% -$2.42K 0.01% 445
2026
Q2 		$49.3K Sell
13,439
-10,025
-43% -$33.4K 0.01% 429
2026
Q1 		$124K Buy
23,464
+3,000
+15% +$11.6K 0.04% 275
2025
Q4 		$83.7K Buy
20,464
+1,363
+7% +$6.75K 0.02% 419
2025
Q3 		$93.2K Sell
19,101
-829
-4% -$4.35K 0.02% 360
2025
Q2 		$101K Sell
19,930
-5,787
-23% -$28.4K 0.02% 277
2025
Q1 		$136K Sell
25,717
-5,106
-17% -$37.2K 0.04% 264
2024
Q4 		$202K Sell
30,823
-4,664
-13% -$31.4K 0.07% 239
2024
Q3 		$234K Buy
35,487
+907
+3% +$6.5K 0.08% 235
2024
Q2 		$268K Buy
34,580
+2,349
+7% +$20.5K 0.1% 207
2024
Q1 		$332K Buy
32,231
+9,438
+41% +$105K 0.22% 111
2023
Q4 		$224K Buy
+22,793
New +$163K 0.17% 136

Other funds holding RXRX

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Sowell Financial Services
Sowell Financial Services North Little Rock, Arkansas $3.12B AUM 22.73% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Interchange Capital Partners's RXRX Position: Q3 2026 in Review

Interchange Capital Partners reduced its Recursion Pharmaceuticals (RXRX) stake by 5.3% in Q3 2026, selling an estimated $2.42K and leaving 12,724 shares worth $52.6K. The position accounts for 0.01% of the portfolio, ranked #445.

Interchange Capital Partners first reported a position in RXRX in Q4 2023 and has held it in 12 quarters since. The position peaked at $332K in Q1 2024. 78 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Interchange Capital Partners held 12,724 shares of Recursion Pharmaceuticals worth $52.6K as of Q3 2026.
  • Interchange Capital Partners sold 715 Recursion Pharmaceuticals shares in Q3 2026, an estimated $2.42K.
  • Recursion Pharmaceuticals made up 0.01% of Interchange Capital Partners's portfolio in Q3 2026, its #445 holding.
  • Interchange Capital Partners first reported a position in Recursion Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • Interchange Capital Partners's Recursion Pharmaceuticals position peaked at $332K in Q1 2024.
  • 78 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Interchange Capital Partners's 13F filing for Q3 2026, filed 28 Oct 2026.